NCT06198972Completed
Pelvic Proprioceptive Neuromuscular Facilitation (PNF) Exercises in Multiple Sclerosis Patients
The Effect of Pelvic Proprioceptive Neuromuscular Facilitation (PNF) Exercises on Strength, Balance and Walking Skills in Multiple Sclerosis Patients.
Source: ClinicalTrials.gov · Last updated 17 Apr 2025
Brief summary (registry, in English)
Multiple Sclerosis (MS) is an autoimmune, demyelinating disease that progresses with motor and sensory loss of the central nervous system and causes disability at different levels. Although signs and symptoms vary depending on the location of the lesion, findings such as loss of muscle strength, spasticity, sensory disorders and fatigue cause decreases in walking function in the majority of patients. Loss of muscle strength and fatigue cause loss of mobility, causing individuals with MS to be less physically active than healthy adults in the same age group. As a result, approximately 40% of individuals with MS have walking problems and approximately 70% of them experience a decrease in daily living activities. Literature studies frequently include strengthening exercises for lower extremity muscles in MS patients. However, the results of pelvic pattern exercises, which are the key to lower extremity movements, are not specified. In this study, which is planned in the light of this information, the findings obtained from pelvic PNF exercises will serve to fill this gap in the literature.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 27 Dec 2023
- Start date
- 1 Jan 2024
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Diseases
- Multiple sclerosis
- NCT number
- NCT06198972
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Jan 2024 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals who cannot tolerate the treatment programs and cannot ensure their continuity (2 weeks in a row) will be excluded from the study.
Who the study is looking for
- Consent for the study was obtained;
- Between 18-50 years of age,
- Extended Disability Status Scale (EDSS) score of 4 and below,
- Not in the habit of exercising regularly
- Can walk on the treadmill,
- Not pregnant,
- Not receiving corticosteroid treatment in the last 1 month,
- Fampridine etc. in the last month. not taking medication,
- Patients who have not received Botox treatment in the last 6 months will be included.
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gaziantep Islam Science and Technology University Coordinator of this site? Confirm its status | Gaziantep | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.